title: Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein α from hematopoietic cells in a family with AML.
authors: M
authors: M
authors: Stelljes
authors: A
authors: A
authors: Corbacioglu
authors: R F
authors: RF
authors: Schlenk
authors: K
authors: K
authors: Döhner
authors: M C
authors: MC
authors: Frühwald
authors: C
authors: C
authors: Rossig
authors: K
authors: K
authors: Ehlert
authors: G
authors: G
authors: Silling
authors: C
authors: C
authors: Müller-Tidow
authors: H
authors: H
authors: Juergens
authors: H
authors: H
authors: Döhner
authors: W E
authors: WE
authors: Berdel
authors: J
authors: J
authors: Kienast
authors: S
authors: S
authors: Koschmieder
mesh_terms: D000328:Adult; D020132:Anticipation, Genetic; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D022763:CCAAT-Enhancer-Binding Protein-alpha / Q000235:genetics*; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D018095:Germ-Line Mutation; D006412:Hematopoietic Stem Cells / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000235:genetics / Q000601:surgery*; D016609:Neoplasms, Second Primary / Q000235:genetics / Q000601:surgery; D009386:Neoplastic Syndromes, Hereditary / Q000235:genetics*; D010375:Pedigree; D036102:Peripheral Blood Stem Cell Transplantation; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma; D012008:Recurrence; D016879:Salvage Therapy; D017741:Survivors; D014184:Transplantation, Homologous
chemical_list: D022763:CCAAT-Enhancer-Binding Protein-alpha